Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02273752 | Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer | terminated | Phase 2 | 2 | Emory UniversityOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00301106 | Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver | terminated | Phase 1 | 2 | Max SungOTHER | 1 | Feb 2, 2017 | clinicaltrials |
| Group-based or Individual Information About Disease and Treatment Plan |
| terminated |
| N/A |
| 98 |
| Norwegian University of Science and TechnologyOTHER |
| 1 |
| Jan 26, 2017 |
| clinicaltrials |
| NCT00537173 | Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer | terminated | — | 11 | Hoosier Cancer Research NetworkOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT00282529 | Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study | terminated | N/A | 400 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 24, 2017 | clinicaltrials |
| NCT00096109 | Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2017 | clinicaltrials |
| NCT00045591 | Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer | terminated | Phase 2 | 39 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT02213744 | MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients(HERMIONE) | terminated | Phase 2 / Phase 3 | 113 | Merrimack PharmaceuticalsINDUSTRY | 9 | Jan 6, 2017 | clinicaltrials |
| NCT01708798 | Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer | terminated | Phase 2 / Phase 3 | 44 | University of British ColumbiaOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT00752986 | ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial(ZACFAST) | terminated | Phase 2 | 39 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
| NCT00912444 | Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer(NATT) | terminated | Phase 3 | 102 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 22, 2016 | clinicaltrials |
| NCT01875198 | Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer | terminated | N/A | 1 | Yonsei UniversityOTHER | 1 | Nov 22, 2016 | clinicaltrials |
| NCT00977379 | A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis(XERAD) | terminated | Phase 2 | 24 | Hoffmann-La RocheINDUSTRY | 1 | Nov 15, 2016 | clinicaltrials |
| NCT01246726 | Multiple Oncological Serial Scans Study(MOSS) | terminated | N/A | 9 | University Hospitals Bristol and Weston NHS Foundation TrustOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT02197949 | Preoperative and Intraoperative Quantification of Axillary Tumoral Load | terminated | — | 12 | Parc de Salut MarOTHER | 1 | Nov 8, 2016 | clinicaltrials |
| NCT00066807 | Premenopausal Endocrine Responsive Chemotherapy Trial(PERCHE) | terminated | Phase 3 | 29 | ETOP IBCSG Partners FoundationNETWORK | 3 | Oct 28, 2016 | clinicaltrials |
| NCT02380209 | An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer | terminated | Early Phase 1 | 8 | University of ArizonaOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT02645175 | Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue | terminated | Phase 2 | 3 | Meriyana Bio Inc.INDUSTRY | 0 | Oct 21, 2016 | clinicaltrials |
| NCT01194869 | Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer | terminated | Phase 2 | 25 | Emory UniversityOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT01188915 | Personalised Program for Women Treated for Hodgkin Disease(PROPER) | terminated | N/A | 51 | Institut Paoli-CalmettesOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT01910844 | Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes(META2) | terminated | Phase 2 | 3 | Centre Jean PerrinOTHER | 1 | Oct 11, 2016 | clinicaltrials |
| NCT01498588 | Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer | terminated | Phase 2 | 7 | Emory UniversityOTHER | 1 | Oct 3, 2016 | clinicaltrials |
| NCT01032447 | Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program | terminated | — | 45 | Stanford UniversityOTHER | 1 | Sep 28, 2016 | clinicaltrials |
| NCT01723124 | Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up | terminated | N/A | 228 | Mayo ClinicOTHER | 1 | Sep 21, 2016 | clinicaltrials |
| NCT00603408 | Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer | terminated | Phase 2 | 5 | Washington University School of MedicineOTHER | 1 | Aug 19, 2016 | clinicaltrials |
| NCT01132664 | Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer | terminated | Phase 1 / Phase 2 | 72 | Novartis PharmaceuticalsINDUSTRY | 6 | Aug 17, 2016 | clinicaltrials |
| NCT01653366 | Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway | terminated | N/A | 4 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 16, 2016 | clinicaltrials |
| NCT01836640 | Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast Cancer | terminated | — | 9 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 16, 2016 | clinicaltrials |
| NCT00805597 | Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes | terminated | Phase 3 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 8, 2016 | clinicaltrials |
| NCT01938651 | Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer | terminated | N/A | 3 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT01568346 | Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy | terminated | Phase 3 | 9 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 2, 2016 | clinicaltrials |
| NCT00427427 | Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer | terminated | Phase 2 | 75 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 1, 2016 | clinicaltrials |
| NCT01528345 | Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer | terminated | Phase 2 | 97 | Novartis PharmaceuticalsINDUSTRY | 15 | Jul 11, 2016 | clinicaltrials |
| NCT01346579 | Biomarkers in Tissue Samples From Older Women With Breast Cancer | terminated | — | 505 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 4, 2016 | clinicaltrials |
| NCT00933088 | Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer | terminated | — | 43 | NYU Langone HealthOTHER | 1 | Jun 24, 2016 | clinicaltrials |
| NCT01339000 | Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy | terminated | Phase 2 | 1 | National Cancer Institute (NCI)NIH | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01805908 | Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (TmAb) in Human Epidermal Growth Factor-2 (HER2) Positive Metastatic Breast Cancer (MBC) or Locally Advanced Breast Cancer (LABC)(PETRA) | terminated | Phase 1 | 3 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 6, 2016 | clinicaltrials |
| NCT00794989 | Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer | terminated | N/A | 20 | Roswell Park Cancer InstituteOTHER | 1 | Jun 3, 2016 | clinicaltrials |
| NCT00429403 | Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer | terminated | Phase 3 | 1 | M.D. Anderson Cancer CenterOTHER | 2 | May 9, 2016 | clinicaltrials |
| NCT00567879 | A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab | terminated | Phase 1 / Phase 2 | 56 | Novartis PharmaceuticalsINDUSTRY | 6 | May 9, 2016 | clinicaltrials |
| NCT01934114 | NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo | terminated | — | 8 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT00346229 | Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer | terminated | Phase 1 | 29 | Duke UniversityOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT00131612 | An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment | terminated | — | 120 | AHS Cancer Control AlbertaOTHER | 1 | Feb 26, 2016 | clinicaltrials |
| NCT00773474 | Lonafarnib in Metastatic Breast Cancer | terminated | Phase 2 | 29 | George SledgeOTHER | 1 | Feb 18, 2016 | clinicaltrials |
| NCT00020722 | Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer | terminated | Phase 2 | 7 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT01796977 | Using A Dissolved Oxygen Enriched Dressing in Nipple-sparing Mastectomy(NSM) | terminated | N/A | 27 | Halyard HealthINDUSTRY | 1 | Feb 17, 2016 | clinicaltrials |
| NCT01029925 | Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL) | terminated | Phase 2 | 7 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 12, 2016 | clinicaltrials |
| NCT01534455 | Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA) | terminated | Phase 2 | 43 | GBG Forschungs GmbHOTHER | 1 | Feb 10, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Feb 3, 2017source: clinicaltrials